State Street Corp Acurx Pharmaceuticals, Inc. Transaction History
State Street Corp
- $2.21 Trillion
- Q1 2024
A detailed history of State Street Corp transactions in Acurx Pharmaceuticals, Inc. stock. As of the latest transaction made, State Street Corp holds 43,466 shares of ACXP stock, worth $94,321. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43,466
Previous 28,566
52.16%
Holding current value
$94,321
Previous $109,000
2.75%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ACXP
# of Institutions
30Shares Held
1.25MCall Options Held
16.1KPut Options Held
33.8K-
Vanguard Group Inc Valley Forge, PA492KShares$1.07 Million0.0% of portfolio
-
Prospect Financial Services LLC Melville, NY273KShares$592,0840.55% of portfolio
-
Geode Capital Management, LLC Boston, MA116KShares$252,4830.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ57.3KShares$124,2320.0% of portfolio
-
Lpl Financial LLC Fort Mill, SC40.2KShares$87,3090.0% of portfolio
About Acurx Pharmaceuticals, Inc.
- Ticker ACXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,556,600
- Market Cap $25.1M
- Description
- Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The com...